(Q34088287)

30 July 2017

1 reference

title

Pharmacogenetics and adverse drug reactions (English)

1 reference

30 July 2017

U A Meyer

1

1 reference

PubMed ID

11089838

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

30 July 2017

1 reference

30 July 2017

356

1 reference

30 July 2017

1667-1671

1 reference

30 July 2017

9242

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Pharmacogenetics and future drug development and delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Molecular mechanisms of genetic polymorphisms of drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Pharmacogenetics and cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

1 reference

7 January 2021

Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Pharmacogenetics of antidepressants: clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

The pharmacogenetics of codeine hypoalgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

The role of innovation in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

The pharmacogenetics of beta2-adrenergic receptors: relevance to asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Angiotensin-converting enzyme gene I/D polymorphism and renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903167-6

7 January 2021

10.1016/S0140-6736(00)03167-6

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11089838